Acadian Asset Management LLC Cytek Biosciences, Inc. Transaction History
Acadian Asset Management LLC
- $48.4 Billion
- Q2 2025
A detailed history of Acadian Asset Management LLC transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 313,644 shares of CTKB stock, worth $1.22 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
313,644
Previous 40,667
671.25%
Holding current value
$1.22 Million
Previous $162,000
557.41%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CTKB
# of Institutions
156Shares Held
74MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY17.1MShares$66.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.77MShares$30.3 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD7.11MShares$27.7 Million0.72% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$26 Million0.93% of portfolio
-
State Street Corp Boston, MA4.17MShares$16.3 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $525M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...